Abstract
Tumor-associated macrophages polarize toward an M2 phenotype and express scavenger receptor A (SR A), hencepromoting tumor progression. We demonstrated that SR A can be therapeutically targeted in vivo with the small peptide inhibitor 4F to prevent metastatic spread. Beyond our study, 4F is emerging as a promising anticancer agent. © 2013 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Neyen, C., Mukhopadhyay, S., Gordon, S., & Hagemann, T. (2013). An apolipoprotein A-I mimetic targets scavenger receptor a on tumor-associated macrophages: A prospective anticancer treatment? OncoImmunology, 2(6). https://doi.org/10.4161/onci.24461
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free